BuzzSparks.org

Lux Capital


Emerging Technology VC

Lux Capital Management is a research-driven investment firm focused on founding, seed and early stage investments in the physical and life sciences. Lux takes an active role in helping entrepreneurs build successful businesses in high growth...

Founded in 2000
Employees: 10
Homepage:

HQ

10017 295 Madison Avenue
24th Floor

New York
New York
USA NY

Phone: 646-475-4385

Updated on Jan 19, 2010
Lux Capital at CrunchBase
Rob Paull Co-Founder and Managing General Partner
Josh Wolfe Co-Founder and Managing Partner
Peter Hebert Co - Founder & Managing Partner
Karen Eliadis CFO
Robert Paull Co-Founder and Managing Partner
Jeffrey B. Kindler Venture Partner
Shahin Farshchi Principal
Larry Bock Special Limited Partner
Adam Goulburn Senior Associate
Tuvia Barak Venture Partner
R. James Woolsey Venture Partner
George Blackburn Senior Advisor
Reese Schroeder Senior Advisor
Jim Woolsey Partner
Bilal Zuberi Partner
Adam Kalish General Partner
Zack Schildhorn V.P. & Director, Operations
Bibi Masara Office Manager
Richard Foster Venture Partner
David Sinclair Venture Partner
Ray Johnson Senior Advisor
Herb Goronkin Venture Partner
Past
Daniel Leff Co-Investors

August, 2013

Lux Capital invested $11.8M in Evolv Technologies as unattributed round

Lux Capital invested $15M in EverSpin Technologies as a Series B round

June, 2013

Lux Capital invested $50M in Kymeta as a Series C round

April, 2013

Lux Capital invested $30M in Shapeways as a Series C round

March, 2013

Lux Capital invested $5.6M in Matterport as a Series A round

February, 2013

Lux Capital invested $11.5M in Kala Pharmaceuticals as a Series A round

January, 2013

Lux Capital invested $11M in Kyruus as a Series B round

November, 2012

Lux Capital invested $13M in Visterra as a Series A round

October, 2012

Lux Capital invested $30M in Genocea Biosciences as a Series C round

August, 2012

Lux Capital invested $12M in Kymeta as unattributed round

July, 2012

Lux Capital invested $30M in Siluria Technologies as a Series C round

June, 2012

Lux Capital invested $6.2M in Shapeways as a Series B round

March, 2012

Lux Capital invested $7.2M in Kala Pharmaceuticals as private_equity round

February, 2012

Lux Capital invested $21.7M in Luxtera as a Series C round

December, 2011

Lux Capital invested $15M in Cerulean Pharma as a Series D round

September, 2011

Lux Capital invested $20M in Siluria Technologies as a Series B round

June, 2011

Lux Capital invested $25M in Transphorm as a Series D round

February, 2011

Lux Capital invested $20M in Transphorm as a Series C round

January, 2011

Lux Capital invested $35M in Genocea Biosciences as a Series B round

November, 2010

Lux Capital invested $24M in Cerulean Pharma as a Series C round

October, 2010

Lux Capital invested $13.3M in Siluria Technologies as unattributed round

August, 2010

Lux Capital invested $4M in Crystal IS as a Series B round

Lux Capital invested $6M in Visterra as a Series A round

November, 2009

Lux Capital invested $14.5M in Cambrios Technologies as a Series D round

July, 2009

Lux Capital invested $10M in Cerulean Pharma as a Series B round

May, 2009

Lux Capital invested $3.3M in Parasol Therapeutics as a Series A round

April, 2008

Lux Capital invested $20M in EverSpin Technologies as a Series A round

January, 2008

Lux Capital invested $8.1M in Cerulean Pharma as a Series B round

November, 2007

Lux Capital invested $8M in Silicon Clocks as unattributed round

May, 2007

Lux Capital invested $12.1M in Cerulean Pharma as a Series A round

August, 2006

Lux Capital invested $10.6M in Crystal IS as a Series B round

November, 2005

Lux Capital invested $41.5M in nanosys as a Series D round

February, 2005

Lux Capital invested $12M in Cambrios Technologies as a Series B round

2000

Lux Capital was founded in 2000